273 related articles for article (PubMed ID: 7693530)
1. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
Layer P; Gröger G
Digestion; 1993; 54 Suppl 2():10-4. PubMed ID: 7693530
[TBL] [Abstract][Full Text] [Related]
2. The effect of enzyme substitution in patients with pancreatic insufficiency.
Worning H
Scand J Gastroenterol; 1980; 15(5):529-33. PubMed ID: 6160608
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.
Layer P; Keller J
J Clin Gastroenterol; 1999 Jan; 28(1):3-10. PubMed ID: 9916657
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
5. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
Pap A; Varró V
Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
[TBL] [Abstract][Full Text] [Related]
7. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy.
Ihse I; Lilja P; Lundquist I
Scand J Gastroenterol; 1980; 15(2):137-44. PubMed ID: 6155686
[TBL] [Abstract][Full Text] [Related]
8. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
[TBL] [Abstract][Full Text] [Related]
9. Fate of oral enzymes in pancreatic insufficiency.
Guarner L; Rodríguez R; Guarner F; Malagelada JR
Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
Löser C; Fölsch UR
Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
[TBL] [Abstract][Full Text] [Related]
11. Fate of pancreatic enzymes during small intestinal aboral transit in humans.
Layer P; Go VL; DiMagno EP
Am J Physiol; 1986 Oct; 251(4 Pt 1):G475-80. PubMed ID: 2429560
[TBL] [Abstract][Full Text] [Related]
12. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
[TBL] [Abstract][Full Text] [Related]
13. Effects of pectin and wheat bran on intraluminal pancreatic enzyme activities and on fat absorption as examined with the triolein breath test in patients with pancreatic insufficiency.
Isaksson G; Lundquist I; Akesson B; Ihse I
Scand J Gastroenterol; 1984 Jun; 19(4):467-72. PubMed ID: 6205439
[TBL] [Abstract][Full Text] [Related]
14. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
Adler G; Mundlos S; Kühnelt P; Dreyer E
Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531
[TBL] [Abstract][Full Text] [Related]
15. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
Lankisch PG
Digestion; 1993; 54 Suppl 2():21-9. PubMed ID: 8224569
[TBL] [Abstract][Full Text] [Related]
16. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
Lieb JG; Patel D; Karnik N; Toskes PP
Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
Trang T; Chan J; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11467-85. PubMed ID: 25206255
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
Domínguez-Muñoz JE
Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
20. [Requirements for successful pancreatic enzyme replacement therapy (comparative study of Kreon and Panpur)].
Pap A; Korom M; Marosi E; Varró V
Orv Hetil; 1990 Feb; 131(5):241-4. PubMed ID: 2304764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
